Commodore Capital L.P., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 256,486 shares at $5.07 ($1.3M) on 2021-10-19, disclosed to the SEC on 2021-10-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.07 | 87,580 | $444K | 33.4% |
| 2 | $5.07 | 87,580 | $444K | 33.4% |
| 3 | $5.44 | 40,663 | $221K | 16.6% |
| 4 | $5.44 | 40,663 | $221K | 16.6% |
| Total | $5.19 avg | 256,486 | $1.3M | 100% |
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |